Skip to main content
. 2016 Nov 7;7(49):81598–81610. doi: 10.18632/oncotarget.13150

Figure 3. Characterization of the sensitivity of NCI-H1975 and NCI-H1975/OSIR cells to EGFR TKIs.

Figure 3

A. NCI-H1975 and NCI-H1975/OSIR cells were treated with indicated concentrations of EGFR TKIs for 72 h. Cell viability was studied using MTT assay. B. The IC50 values of EGFR TKIs in NCI-H1975 and NCI-H1975/OSIR cells.